Search

everythinglearnresearchcommunity

for

Search:↓

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

A genetic mutation in the EDA gene causes hypohidrotic ectodermal dysplasia in cats.

Sostdc1 controls the size and number of hair and mammary gland structures.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

Mutations in hKAP1 genes may cause hereditary hair disorders.

CCC1 is essential for ion balance and proper plant cell function.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

NonClassic Congenital Adrenal Hyperplasia is a less severe form of a genetic disorder affecting adrenal gland function.

Variants in the CCDC47 gene are linked to trichohepatoneurodevelopmental syndrome.

A specific gene change is linked to severe hair loss.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Zinc supplements improved the girl's skin and hair condition.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Trichoscopy is effective for diagnosing scalp ACC in darker skin tones.

New mutations in the SLC39A4 gene found in twins help understand the genetic cause of acrodermatitis enteropathica.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

Recognizing IPPP is crucial to prevent misdiagnosis and unnecessary treatments.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

AH-001 could be a safer and more effective treatment for hair loss.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

PDCD4 is important for controlling skin cell growth and healing.

Scientists created cell lines to study a genetic skin disorder using CRISPR technology.

A PKP1 gene mutation causes skin fragility and hair loss in Chesapeake Bay retriever puppies.